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Abstract
Background:  Concomitant treatment in addition to intervention may influence the primary
outcome, especially in complex interventions such as surgical trials. Evidence-based standards for
perioperative care after distal pancreatectomy, however, have been rarely defined. This study's
objective was therefore to identify and analyse the current basis of evidence for perioperative
management in distal pancreatectomy.
Methods: A standardised questionnaire was sent to 23 European centres recruiting patients for a
randomized controlled trial (RCT) on open distal pancreatectomy that would compare suture
versus stapler closure of the pancreatic remnant (DISPACT trial, ISRCTN 18452029).
Perioperative strategies (e.g., bowel preparation, pain management, administration of antibiotics,
abdominal incision, drainages, nasogastric tubes, somatostatin, mobilisation and feeding regimens)
were assessed. Moreover, a systematic literature search in the Medline database was performed
and retrieved meta-analyses and RCTs were reviewed.
Results: All 23 centres returned the questionnaire. Consensus for thoracic epidural catheters
(TECs), pain treatment and transverse incisions was found, as well as strong consensus for the
placement of intra-abdominal drainages and perioperative single-shot antibiotics. Also, there was
consensus that bowel preparation, somatostatin application, postoperative nasogastric tubes and
intravenous feeding might not be beneficial. The literature search identified 16 meta-analyses and
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19 RCTs demonstrating that bowel preparation, somatostatin therapy and nasogastric tubes can
be omitted. Early mobilisation, feeding and TECs seem to be beneficial for patients. The value of
drainages remains unclear.
Conclusion: Most perioperative standards within the centres participating in the DISPACT trial
are in accordance with current available evidence. The need for drainages requires further
investigation.
Trial registration: Clinical trial registration: ISRCTN 18452029
Background
Short-term outcomes after major abdominal surgery are
influenced by indication, surgical intervention, the sur-
geons' expertise, hospital volume and perioperative man-
agement [1-5]. In order to qualitatively assess the impact
of the various factors on outcome, a rigorous means of
evaluation such as the randomized controlled trial (RCT)
design is necessary. Mortality and morbidity in pancreatic
surgery has decreased in high-volume centres in recent
years [6,7] mainly by virtue of standardised surgical and
optimised perioperative management [8]. In high volume
centres, mortality from distal pancreatectomy is as low as
5% while morbidity remains as high as 40% [7,9-12].
Morbidity is determined by perioperative factors such as
bowel preparation, incision type, analgesia, mobilisation,
and feeding regimens, amongst other factors [1]. In addi-
tion, long-term survival after pancreatectomy as cancer
treatment strongly depends on a centre's operative vol-
ume [13].
A recent study of 617 consecutive pancreatic resections
demonstrated local complications to be more frequent
than systemic complications [14]. Thus, the formation of
pancreatic fistulas can be considered the most important
complication after a pancreatic left resection. Currently,
the Study Centre of the German Surgical Society is con-
ducting a large RCT (DISPACT trial, ISRCTN 18452029)
to compare the occurrence rates of pancreatic fistula after
stapler versus hand-sewn closure of the pancreas after left
resections [15]. Both expert opinions and evidence-based
standards were taken into account in the development of
the study protocol. The consensus-assisted development
of study protocols has proven to be beneficial and may
indeed be helpful in identifying when consensus is
present but not justified by evidence [16]. All 23 centres
Table 1: Total pancreatectomies and distal pancreatic resections performed in 2008 at centres taking part in DISPACT Trial
Centre Number of pancreatic resections Number of distal pancreatectomies Number of patients randomized in
2008
Amsterdam, Netherlands 76 12 8
Berlin Charité Mitte, Germany 20 12 4
Berlin Charité Virchow, Germany 197 48 20
Berlin Lichtenberg, Germany 38 10 4
Bochum St. Josef, Germany 214 46 7
Dresden-Friedrichstadt, Germany 52 5 2
Freiburg, Germany 83 15 2
Gent, Belgium 68 6 3
Heidelberg, Germany 423 87 45
Homburg, Germany 61 10 -
Cologne-Merheim, Germany 25 10 -
Liverpool, Great Britain 128 13 1
Ljubljana, Slovenia 90 25 10
Mannheim, Germany 71 10 4
Marburg, Germany 48 13 1
Munich-LMU, Germany 91 19 13
Munich-TU, Germany 87 27 22
Regensburg, Germany 70 19 6
Verona, Italy 269 66 17
Würzburg, Germany 20 7 2
Wuppertal, Germany 24 3 1
Total 2155 463 172
Median (range) 71 (20–423) 13 (3–87) 4 (0–45)Trials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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contributing to DISPACT are centres with a substantial
caseload of pancreatic left resection (Table 1). The study
protocol of DISPACT has been approved by the ethics
committees of all participating centres and has been
recently published [15]. Since the DISPACT trial aims to
evaluate the effect of two surgical procedures (stapler and
hand-sewn closure) on the development of pancreatic fis-
tula, surgical and perioperative standardisation is of spe-
cial interest. The present study was launched during an
investigator meeting to identify the current practices con-
cerning perioperative management amongst the various
participating centres. This study aims to identify the level
of consensus of relevant factors in perioperative manage-
ment. In addition, an extensive literature search was con-
ducted to compare findings with current best available
evidence.
Methods
Survey of current practice
Twenty-three European centres participating in the DIS-
PACT trial were evaluated using a standardized question-
naire to evaluate perioperative management [see
Additional file 1]. Standards in bowel preparation, pain
and feeding management, antibiotics prophylaxis, inci-
sion type, drainages, necessity and duration of intensive
care, mobilisation and perioperative somatostatin therapy
were assessed. These relevant items were identified in a
previously published meta-analysis and included in the
questionnaire [17]. The survey was designed by T.L.,
N.N.R. and C.M.S and mailed to all centres taking part in
the DISPACT trial. The survey was completed and
returned by all local surgical sub-investigators. Consensus
levels were classified for each outcome as published else-
where [18]. Briefly, a discrete scale was used and the
results were stratified along consensus levels 1 – 4, which
in turn corresponded to being standard in <50% (no con-
sensus), 50–75% (overall agreement), 75–95% (consen-
sus), and >95% (strong consensus) of participating
centres, respectively.
For time-critical factors such as the removal of intra-
abdominal drainages, thoracic epidural catheters (TECs)
and gastric tubes; the discharge from intensive care unit
(ICU) or intermediate care (IMC) wards; and the duration
of intravenous feeding and somatostatin therapy, median
time and interquartile ranges (IQRs) have been calcu-
lated.
Literature search of best practice
Only RCTs or meta-analyses of RCTs assessing periopera-
tive care were eligible for inclusion. Since specific evi-
dence of perioperative care for distal pancreatectomy and
pancreatic surgery was expected to be low, articles on gen-
eral abdominal surgery including hepatic and colorectal
surgery were included as well and evaluated in hierarchi-
cal order (distal pancreatectomy > pancreatic surgery >
abdominal surgery > hepatic and colorectal surgery).
Studies of paediatric, laparoscopic, and transplantation
surgery were excluded. A search algorithm was developed
and an extensive systematic Medline search using Boolean
operator functions and wildcards (i.e. the asterisk sym-
bol) was performed independently by three authors of
this study (H.B., N.N.R. and T.L.). The search algorithm
used single relevant keywords, medical subject headings
(MESH), and their combinations (Appendix 1). No other
literature databases than Medline were searched and a
subsequent analysis of the identified literature was per-
formed. All published articles were evaluated.
Reference lists of the retrieved literature were manually
cross-searched for additional publications independently
by three researchers (T.L., N.N.R and H.B.) under the
supervision of an experienced researcher (C.M.S.). More-
over, captured citations were filtered for study design in
order to identify all RCTs and meta-analyses. Titles,
abstracts, and full text articles were screened for the selec-
tion of relevant studies.
Results
Survey of current practice
All 23 centres participating in the DISPACT trial returned
completely filled out questionnaires either per fax, mail or
email. The annual caseload of pancreatic resections for
each centre within the year 2008 is given in Table 1. All
centres performed at least 20 pancreatic resections, which
was the requirement for participation in the DISPACT
trial. Pancreatic left resections (median 13; range 3–87)
are performed less commonly than other resections. Only
two centres have not randomized patients for DISPACT
within the last year. Median 4 patients (range 0–45) were
randomized. The random ratio (randomized left resec-
tions/total left resection * 100) was 37%.
Bowel preparation
Mechanical bowel preparation (MBP) as a standard was
performed at eight of the 23 participating centres (Table
2). Enemas were made use of at seven centres and one cen-
tre performed orthograde lavage; 14 hospitals did not use
any kind of MBP before left pancreatectomy (Table 2).
Type of incision, intraoperative antibiotics and placement of 
abdominal drainages
The transverse incision was exclusively used by 16 hospi-
tals and the midline by four hospitals. Two centres used
other types of incisions and one centre used both inci-
sions, depending on the individual surgeon's choice
(Table 2). Intraoperative single-shot antibiotics were per-
formed in all but one centre (Table 2).
All centres placed intra-abdominal drainages. Drains were
left for median of four days (IQR 3–5), with a maximum
of eight days at one centre (Table 2).Trials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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Postoperative care
Postoperatively, 17 centres transferred their patients to
ICU or IMC wards, whereas five centres transferred
patients directly to nursery wards. Patients were dis-
charged from ICU and IMC after a median of one day
(IQR 1-1) and two days (IQR 1–2.25), respectively
(Table 2).
Pain management
Thoracic epidural catheters (TECs) were used in 20 hospi-
tals and kept in place for a median duration of four days
(IQR 3–5) (Appendix 1). Fifteen centres used a combina-
tion of local anaesthetics and opioids for the medication
of TECs and three centres used exclusively local anaesthet-
ics (Appendix 1). Two centres did not specify the medica-
tion.
Nasogastric tube and feeding regimens
Postoperatively, a nasogastric tube was placed for a
median of one day (IQR 1–2) in 10 hospitals (Table 2).
Eleven centres used parenteral feeding for a median of two
days (IQR 1.5–2) (Table 2). Oral feeding with fluids
started on day 1 (IQR (0–1) and solid food on day 2 (IQR
2–3) (Table 3). One centre reported keeping patients on
parenteral feeding till day 5 and starting oral feeding with
fluids and solids on day 5.
Mobilisation
Mobilisation of patients started at postoperative day 1
(IQR 0–1) (Table 3). Eight centres started mobilisation on
the operative day, while 14 centres started on first postop-
erative day. One centre reported starting mobilisation on
the second postoperative day.
Table 2: Perioperative standards in the 23 European centres for pancreatic surgery
n % consensus level median duration (IQR)
Bowel preparation
none 15 65 overall agreement -
enema 7 30 -
orthograde lavage 1 4 -
Type of incision
Midline+ 52 2 -
Transverse+ 18 78 consensus -
Other 2 4 -
Intraoperative single-shot antibiotic prophylaxis
No 1 4 -
Yes 22 96 strong consensus -
Intra-abdominal drainages
No 0 0
Yes 23 100 strong consensus 4 (3–5)
Postoperative care
IMC** 9 39 2 (1–2.25)
ICU** 11 48 1 (1-1)
Nursery ward 5 22 -
Not specified 1 4 -
Pain management (thoracic epidural catheter)
No 3 13 -
Yes* 20 87 consensus 4 (3–5)
Post-operative gastric tube
No 13 57 overall agreement -
Yes 10 43 1 (1–2)
Intravenous feeding
No 12 52 overall agreement -
Yes 11 48 2 (1.5–2)
Somatostatin therapy
No 15 65 overall agreement -
Yes 8 35 6 (3.75–7)
+ One centre reported using both midline and transversal incisions frequently.
*Local anaesthetics and opioids were used at 75% of the centres (n = 15), 15% (n = 3) used local anaesthetics without opioids, and 10% (n = 2) did 
not specify administered drugs.
** Patients were transferred from the ICU to the IMC at three centres. While there is no consensus whether patients should be transferred to the 
ICU or IMC, there is an overall agreement in 74% of centres (n = 17) that patients should not be returned to nursery wards immediately after distal 
pancreatectomy.Trials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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Somatostatin therapy
Fifteen centres did not use Somatostatin as a routine after
pancreatic surgery. In eight centres, somatostatin was used
as a standard after left pancreatectomy for a median of six
days (IQR 3.75–7) (Appendix 1).
Literature search of best practice
All of the identified studies focus on large bowel surgery.
Besides pancreatic surgery, other procedures have been
included based on the similarity in concepts of periopera-
tive management and determinants of complications.
A total of 16 meta-analyses of RCTs and 19 RCTs were
identified and reviewed [see Additional file 2].
Bowel preparation
We identified two meta-analyses [19,20] which included
16 RCTs and six RCTs [21-26] with a total number of 3046
patients and 3747 patients, respectively [see Additional
file 2]. All of these studies failed to identify a benefit from
bowel preparation; both meta-analyses [19,20] and two
of the six RCTs [21,25] found beneficial effects of no
bowel preparation in terms of decreased anastomotic
leakage and/or wound infections. Slim et al. [19] and
Guenaga et al. [20] identified a rate of 6.3% vs. 3.2% (p =
0.003) and 5.6% vs. 3.2% (p = 0.032) for bowel prepara-
tion versus no bowel preparation, respectively [see Addi-
tional file 2].
Type of incision
While complication rates were not different in the meta-
analysis by Brown et al. [27] in transversal versus midline
incisions, a recent RCT by Fassiadis et al. [28] identified a
decreased risk of incisional hernia after transverse incision
for abdominal aortic aneurysm repair only (p = 0.01; [see
Additional file 2]. Moreover, Brown et al. [27] suggested
that transverse incisions may be less painful (odds ratio
[OR] for less analgesic use (mg morphine equivalent) for
total hospital stay, -6.29; 95% CI [-12.57; -0.01]) and may
affect pulmonary function less than midline access (OR
for percentage change in forced expiratory volume in one
second on the last day of measurement, 18.31; 95% CI
[6.84; 29.78]).
Perioperative antibiotic prophylaxis
Regarding antibiotic prophylaxis, the meta-analysis by
Song et al. [29], which included 147 RCTs, showed single-
shot antibiotics to be as effective as long-term antibiotics
in the prevention of surgical wound infections [see Addi-
tional file 2]. The recent study by Fujita et al. [30] identi-
fied a dose-dependent correlation between surgical site
infections and antibiotics (p = 0.009; [see Additional
file 2].
Abdominal drainages
Gurusamy et al. [31] included five trials and 465 patients
in their meta-analysis [see Additional file 2]. No signifi-
cant influence of drainages on complication rates after
liver resection was found [see Additional file 2] [31].
Petrowsky et al. [32] were able to identify surgical proce-
dures after which abdominal drainages significantly
decrease complications (i.e. oesophageal resection and
total gastrectomy) and in which abdominal drainages can
be omitted (i.e. hepatic, rectal or colonic resection with
primary anastomosis, and appendectomy) [see Addi-
tional file 2]. In a RCT by Conlon et al. [33], no correla-
tion between the placement of abdominal drainages and
the need for interventional drainages and surgical explo-
ration after septic complications in patients undergoing
pancreatectomy was detected [see Additional file 2]. For
hepatectomy, Sun et al. [34] were able to identify a corre-
lation of abdominal drainages and postoperative wound
complications in a RCT (28% vs. 3%, p < 0.001; [see Addi-
tional file 2].
Pain management
In their meta-analysis of 16 RCTs, Marret et al. [35] did
not identify any differences in length of hospitalisation
between patients receiving epidural or parenteral analge-
sia after colorectal surgery [see Additional file 2]. Wera-
watganon et al. [36], who included 711 patients from
nine RCTs in their analysis, and Wu et al. [37] identified
better pain relief with epidural analgesia compared to
intravenous analgesia [see Additional file 2]. In a meta-
analysis by Jørgensen et al. [38], a decreased rate of gas-
trointestinal paralysis with comparable effect on pain was
found for epidural local anaesthetics compared to opioid-
based medication [see Additional file 2]. In RCTs, Flisberg
et al. [39] and Mann et al. [40] were able to identify better
pain relief with epidural analgesia and less frequent side
effects compared to i.v. analgesia during rest (p < 0.003)
and mobilisation (p < 0.001) [39] and rest (p < 0.001)
and coughing (p < 0.002) [40], respectively [see Addi-
tional file 2].
Nasogastric tubes
Two meta-analyses by Nelson et al. [41,42] did not iden-
tify any advantage of routinely placed gastric tubes after
abdominal surgery [see Additional file 2]. Additionally,
an earlier return of bowel function was found in patients
without gastric tube in both studies (p < 0.001) [41,42]
[see Additional file 2]. Pesseaux et al. [43] included 200
patients after hepatic resection in a RCT and did not find
Table 3: Mobilisation and oral feeding
Begin of... postoperative day (median (IQR))
...mobilisation 1 (0–1)
...oral feeding
Fluids 1 (0–1)
Solid food 2 (2–3)Trials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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an advantage for nasogastric tubes. They demonstrated an
increased risk of pulmonary complications (i.e. pneumo-
nia and atelectasis, p = 0.047 and p = 0.043, respectively)
within the nasogastric tube group [see Additional file 2]
[43].
Feeding regimens
Andersen et al. [44] included 13 RCTs with 1173 patients
in their meta-analysis. No advantage for late return to oral
diet was found [see Additional file 2] [44]. Han-Geurts et
al. [45], who included 128 patients in a RCT on early (i.e.
within the first two postoperative days) versus late (i.e.
more than two days after procedure) postoperative return
to oral diet, also failed to identify a significant difference
in or beneficial effect of keeping patients starved in terms
of postoperative ileus and recovery [see Additional file 2].
Mobilisation
Three RCTs [46-48] on postoperative mobilisation and
physiotherapy were available [see Additional file 2].
While Browning et al. [46] concluded that early mobilisa-
tion may decrease hospitalisation length, Mackay et al.
[48] did not find a benefit of chest physiotherapy in high
risk patients after open abdominal surgery as far as pul-
monary complications are concerned [see Additional file
2]. In the larger study by Fagevik Olsén et al. [47], chest
physiotherapy decreased postoperative pulmonary com-
plications and improved the mobilisation of patients (6%
in physiotherapy group vs. 29% in control group; p <
0.001; [see Additional file 2].
Somatostatin therapy
While Connor et al. [49] and Alghamdi et al. [50] identi-
fied a reduced complication rate in their meta-analyses on
somatostatin versus no somatostatin after pancreatic sur-
gery (p = 0.003 [49] and p = 0.004 [50]), Zeng et al. [51]
did not find any significant effect on morbidity [see Addi-
tional file 2]. All included meta-analyses [49-51] failed to
identify any effect of somatostatin on mortality rates [see
Additional file 2].
No beneficial effect of somatostatin was found in all
included RCTs [52,53] on somatostatin after pancreatic
surgery [see Additional file 2]. Hesse et al. [52] did not
identify any reduced rate of pancreatic fistula. Even worse,
Shan et al. [53] in their study found delayed gastric emp-
tying to be more frequent in the somatostatin group.
Discussion
Surgical and perioperative management remains a matter
of debate. Besides surgical expertise and technique [9,13],
perioperative procedures significantly influence morbid-
ity [1,6]. This survey of 23 centres participating in a large
multicenter trial on pancreatic left resection revealed that
general perioperative standards can be detected in pancre-
atic surgery. In most items, at least overall agreement was
present. Strong consensus was found in two items (i.e.
placement of abdominal drainages and intraoperative
antibiotic prophylaxis) and consensus was present for the
usage of TECs for pain medication and transversal inci-
sions as the abdominal cavity opening (Table 2). The DIS-
PACT centres agreed overall that no bowel preparation,
gastric tube, somatostatin therapy or intravenous feeding
was necessary after left pancreatectomy (Table 2).
While most of the strategies and standards in the DIS-
PACT group are in accordance with current evidence, this
survey has detected some differences in the perioperative
management after pancreatic left resection despite current
available evidence from meta-analyses and RCTs.
Bowel preparation
As early as 1972, Hughes [54] has questioned the benefi-
cial effect of bowel preparation in large-bowel surgery.
However, this tradition has remained a standard in
abdominal surgery for decades. Within the DISPACT
group, there was overall agreement that no bowel prepa-
ration is necessary before pancreatic left resection (Appen-
dix 1). Based on the results from our literature research,
this standard is in accordance with current evidence.
Recent meta-analyses [19,20] and RCTs [21-26] did not
identify any benefit from bowel preparation before
abdominal surgery (Table 3A). In both meta-analyses by
Guenaga et al. and by Slim et al. [19,20], an increased rate
of anastomotic leakage was identified. Moreover, bowel
preparation may even be disadvantageous in terms of
wound infections [19-21].
In eight (35%) of 23 DISPACT centres, bowel preparation
was used as a standard prior to left pancreatectomy. This
is in contrast to the results of studies conducted in color-
ectal surgery demonstrating no significant differences for
anastomotic leakage rates and overall morbidity [see
Additional file 2] [19-26]. While there is no evidence that
enema or orthograde lavage may be harmful in pancreatic
surgery, it seems likely that there is no benefit from bowel
preparation. Therefore, bowel preparation can no longer
be considered as a necessary standard in pancreatic sur-
gery. Most DISPACT centres have therefore already
stopped any bowel preparation.
Type of incision
A recent meta-analysis did not show any significant differ-
ence between midline and transverse incision as far as
complication rates, incisional hernias and recovery times
[see Additional file 2] [27,28]. Amongst the DISPACT cen-
tres, there was consensus (78%) that a transverse incision
may be more beneficial for distal pancreatectomy (Table
2). While the meta-analysis by Brown et al. [27] failed to
identify any difference between groups with midline andTrials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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transverse abdominal incisions, Fassiadis et al. [28] found
increased rates of incisional hernia in patients undergoing
surgery for aortic aneurysms after midline versus transver-
sal incision (20 of 22 patients versus 6 of 15 patients,
respectively). This finding is confounded by the underly-
ing connective tissue disorders which is a causative agent
for both diseases and therefore may not be relevant for
benign and malignant pancreatic disorders [55-57].
Therefore, the practise of the DISPACT centres is in
accordance with the evidence.
Antibiotic prophylaxis
Antibiotic prophylaxis significantly reduces surgical site
infections as long as local tissue concentrations reach an
effective level [see Additional file 2] [29,30]. Both single-
shot and long-term antibiotics are equally effective. As a
result, antibiotic prophylaxis is a common procedure in
surgery.
All but one centre agreed on using single-shot antibiotics
before left pancreatectomy (Appendix 1). Given the ubiq-
uitous use of antibiotic prophylaxis in surgery, it can be
suspected that one centre chose a different regime and
may have used a long-term antibiotic prophylaxis.
Abdominal drainages
Placement of drainages has a long tradition in abdominal
surgery and can be dated back to the 19th century. While
many surgical procedures originating from these times
have been omitted, Lawson Taits advice of "when in
doubt, drain" is still considered standard in many surgical
centres [58]. Not surprisingly, all centres taking part in the
DISPACT trial agreed on using intra-abdominal drainages
as a standard after distal pancreatectomy (Table 2). There
were considerable differences in time concerning the
removal of drainages, though; the median day of removal
was the fourth postoperative day (IQR 3–5). Some centres
kept drainages as a standard for up to eight days.
The detection of postoperative pancreatic fistulas accord-
ing to the consensus definition requires a drainage for at
least three days [59]. Since the occurrence of pancreatic
fistula is the primary endpoint of the DISPACT trial, place-
ment of abdominal drainages had to be included as a
standard in the study protocol. Unfortunately, there is evi-
dence that intra-abdominal drainages are not beneficial in
all cases and sometimes may even be harmful [see Addi-
tional file 2] [31-34]. For a number of procedures (i.e.
liver resection, appendectomy and colonic or rectal resec-
tion with primary anastomosis), there is no need for
abdominal drainages while for other procedures (i.e.
oesophageal resection or total gastrectomy) there are
proven benefits [32]. Moreover, wound complications
may even be more common when drainages are placed
[34].
A recent RCT by Conlon et al. [33] failed to show a
decreased mortality or rate of complications by intraperi-
toneal drainages after pancreatectomy [see Additional file
2]. A total number of 179 patients were included. Forty of
them underwent distal pancreatectomy; data was consist-
ent among the different procedures in pancreatic surgery.
No reduced need for interventional drainages and surgical
exploration for septic complications was found in the
drainage group [33].
In summary, the value of drainages in pancreatic surgery
remains unclear. Further studies are necessary to resolve
the currents uncertainties regarding drainages after pan-
creatic surgery.
Postoperative care
Most centres (74%) agree that patients undergoing distal
pancreatectomy should be transferred to ICU or IMC
wards (Table 2). In 22% of the DISPACT centres, patients
are transferred directly to regular nursery wards. No meta-
analyses or RCTs were identified in our Medline research
regarding this topic.
Pain management
Pain management is generally considered a key factor of
fast track concepts in surgery and a determinant of hospi-
talisation length [60,61]. In 20 (87%) of the DISPACT
centres, a thoracic epidural catheter was used for pain
management. Fifteen centres (75%) applied regimens
consisting of local anaesthetics and opioids (Table 2).
While overall time of hospitalisation is not significantly
different between patients receiving epidural and
parenteral opioids, epidural administration significantly
decreases side effects [see Additional file 2] [35-37,39,40].
In RCTs published by Filsberg et al. [39] and Mann et al.
[40], epidural versus intravenous application of pain
medication was compared [see Additional file 2]. Opioid-
related gastrointestinal side effects especially are less fre-
quent in epidural analgesia groups [39,40]. In the study
by Jørgensen et al. [38], no difference in pain relief could
be detected between opioid-based analgesia and analgesia
using epidural application of local anaesthetics only.
Within the DISPACT group, thoracic epidural catheters
(TEC) were clearly preferred for pain management and
placed for median of four days (IQR 3-3, Table 2). The
preference for opioids in this context seems to be ques-
tionable.
Nasogastric tubes
Most DISPACT centres do not apply post-operative gastric
tubes as a standard after distal pancreatectomy (Table 2).
Ten centres (43%) keep nasogastric tubes in place for a
median of one day (IQR 1–2) (Table 2). Both meta-anal-
yses and RCTs with a total number of 9634 included
patients could not detect benefits from nasogastric tubesTrials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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after abdominal surgery [see Additional file 2] [41-43].
Contrary to traditional belief, gastric tubes as a postoper-
ative standard seem to be associated with a higher risk of
pulmonary complications and delayed return of bowel
function [see Additional file 2] [41-43]. Postoperative
removal of nasogastric tubes is a standard based on evi-
dence.
Feeding regimens
Administration of oral fluids was performed on median
postoperative day 1 (IQR 0–1) and of solid food on day 2
(IQR 2–3) (Table 3). Most centres did not perform intra-
venous feeding (Table 2). Both the RCT by Han-Geurts et
al. [45] and the meta-analyses by Andersen et al. [44] did
not find any benefit in keeping patients starved after
abdominal surgery [see Additional file 2]. Since an early
(i.e. second postoperative day) return to an oral diet is not
associated with increased postoperative complications,
there is no rationale in keeping patients starved [see Addi-
tional file 2] [44,45].
Mobilisation
Early postoperative patient mobilisation (median postop-
erative day 1 (IQR 0–1) is performed in most of the cen-
tres (Table 3)). While early mobilisation actually may
reduce length of hospitalisation, the value of postopera-
tive chest physiotherapy remains unclear [see Additional
file 2] [46-48]. Mackay et al. [48] could not detect any sig-
nificant decrease in pulmonary complications with chest
physiotherapy in high risk patients. Contrary to this, Fage-
vik et al. [47] reported a significant decrease in postoper-
ative pulmonary complications and an improved
mobilisation with chest physiotherapy [see Additional
file 2].
Somatostatin therapy
Fifteen (65%) DISPACT centres do not use somatostatin
as a postoperative standard (Appendix 1). All reviewed
studies agree that prophylactic somatostatin does not
decrease mortality [see Additional file 2] [49-53,62]. As
far as meta-analyses are concerned, the effect of somato-
statin on the occurrence of pancreatic fistula remains
unclear [49-51]. All reviewed RCTs not only agree that
somatostatin does not have any influence on occurrence
of pancreatic fistula, but Shan et al. [53] also found
increased rates of delayed gastric emptying after prophy-
lactic somatostatin administration and provided
decreased plasma motilin levels as a possible mechanism
[see Additional file 2] [52,62]. Therefore, somatostatin as
a postoperative standard should be avoided.
Conclusion
Evidence-based perioperative management is an impor-
tant cornerstone for a successful outcome after complex
surgical procedures. The results of this survey and the
comparison with the current available evidence detected
some inconsistencies in perioperative management of
patients with pancreatic left resection. At least overall
agreement was present in most items and was – with the
exception of abdominal drainages – in accordance with
strategies that were identified as beneficial for the patients
from our literature research. Evidence-based perioperative
treatment in pancreatic surgery requires the further con-
duct of randomized controlled trials.
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Appendix 1
Items and corresponding search algorithms used for 
Medline search of literature-based standards
Bowel preparation
(Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (Mechan-
ical bowel preparation [tw] OR bowel preparation [tw]
OR bowel cleansing [tw] OR colon preparation [tw]) AND
(randomized controlled trial [pt] OR controlled clinical
trial [pt] OR randomized controlled trials [MESH] OR
random allocation [MESH] OR double-blind method
[MESH] OR single-blind method [MESH] OR clinical trial
[pt] OR clinical trials [MESH] OR ("clinical trial" [tw]) OR
((singl* [tw] OR doubl* [tw] OR tripl* [tw]) AND (mask*
[tw] OR blind* [tw])) OR placebos [MESH] OR placebo*
[tw] OR random* [tw] OR research design [mh:noexp]
OR Meta-Analysis [ptyp] OR systematic review [tw] NOT
(animal [MESH] NOT human [MESH]) NOT case reports
[pt] NOT Comment [PT] NOT letter [PT] NOT childTrials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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[MESH] NOT infant [MESH] NOT child [MESH] NOT
infant [MESH])
Thoracic epidural catheter
((Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (Thoracic
epidural catheter [tw] OR epidural catheter* [tw] OR epi-
dural analgesia [MESH] OR epidural opioid [tw] OR epi-
dural local anaesthetic [tw]) AND (randomized
controlled trial [pt] OR controlled clinical trial [pt] OR
randomized controlled trials [MESH] OR random alloca-
tion [MESH] OR double-blind method [MESH] OR sin-
gle-blind method [MESH] OR clinical trial [pt] OR clinical
trials [MESH] OR ("clinical trial" [tw]) OR ((singl* [tw]
OR doubl* [tw] OR tripl* [tw]) AND (mask* [tw] OR
blind* [tw])) OR placebos [MESH] OR placebo* [tw] OR
random* [tw] OR research design [mh:noexp] OR Meta-
Analysis [ptyp] OR systematic review [tw] NOT (animal
[MESH] NOT human [MESH]) NOT case reports [pt] NOT
Comment [PT] NOT letter [PT] NOT child [MESH] NOT
infant [MESH])
Somatostatin
(Gastrointestinal surgery [tw] OR pancreas surgery [tw]
OR pancreas resection [tw] OR pancreatic surgery [tw] OR
pancreatic resection [tw] OR distal pancreatectomy [tw]
OR pancreatic left resection [tw] OR pancreaticoduo-
denectomy [tw]) AND (somatostatin [tw] OR octreotide
[tw] OR vapreotide [tw] OR lanreotide [tw]) AND (rand-
omized controlled trial [pt] OR controlled clinical trial
[pt] OR randomized controlled trials [MESH] OR random
allocation [MESH] OR double-blind method [MESH] OR
single-blind method [MESH] OR clinical trial [pt] OR
clinical trials [MESH] OR ("clinical trial" [tw]) OR
((singl* [tw] OR doubl* [tw] OR tripl* [tw]) AND (mask*
[tw] OR blind* [tw])) OR placebos [MESH] OR placebo*
[tw] OR random* [tw] OR research design [mh:noexp]
OR Meta-Analysis [ptyp] OR systematic review [tw] NOT
(animal [MESH] NOT human [MESH]) NOT case reports
[pt] NOT Comment [PT] NOT letter [PT] NOT child
[MESH] NOT infant [MESH])
Incision
(Surgery [MESH]) AND (midline incision [tw] OR trans-
verse incision [tw] OR abdominal incision [tw] OR mid-
line laparotomy [tw] OR transverse laparotomy [tw])
AND (randomized controlled trial [pt] OR controlled
clinical trial [pt] OR randomized controlled trials [MESH]
OR random allocation [MESH] OR double-blind method
[MESH] OR single-blind method [MESH] OR clinical trial
[pt] OR clinical trials [MESH] OR ("clinical trial" [tw]) OR
((singl* [tw] OR doubl* [tw] OR tripl* [tw]) AND (mask*
[tw] OR blind* [tw])) OR placebos [MESH] OR placebo*
[tw] OR random* [tw] OR research design [mh:noexp]
OR Meta-Analysis [ptyp] OR systematic review [tw] NOT
(animal [MESH] NOT human [MESH]) NOT case reports
[pt] NOT Comment [PT] NOT letter [PT] NOT child
[MESH] NOT infant [MESH])
Antibiotic prophylaxis
(Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (Antibi-
otic prophylaxis [tw] OR single shot [tw] OR
antimicrobial prophylaxis [tw]) AND (randomized con-
trolled trial [pt] OR controlled clinical trial [pt] OR rand-
omized controlled trials [MESH] OR random allocation
[MESH] OR double-blind method [MESH] OR single-
blind method [MESH] OR clinical trial [pt] OR clinical tri-
als [MESH] OR ("clinical trial" [tw]) OR ((singl* [tw] OR
doubl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind*
[tw])) OR placebos [MESH] OR placebo* [tw] OR ran-
dom* [tw] OR research design [mh:noexp] OR Meta-
Analysis [ptyp] OR systematic review [tw] NOT (animal
[MESH] NOT human [MESH]) NOT case reports [pt] NOT
Comment [PT] NOT letter [PT] NOT child [MESH] NOT
infant [MESH] NOT child [MESH] NOT infant [MESH])
Nasogastric tube
(Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (Nasogas-
tric decompression [tw] OR nasogastric tube [tw]) AND
(randomized controlled trial [pt] OR controlled clinical
trial [pt] OR randomized controlled trials [MESH] OR
random allocation [MESH] OR double-blind method
[MESH] OR single-blind method [MESH] OR clinical trial
[pt] OR clinical trials [MESH] OR ("clinical trial" [tw]) OR
((singl* [tw] OR doubl* [tw] OR tripl* [tw]) AND (mask*
[tw] OR blind* [tw])) OR placebos [MESH] OR placebo*
[tw] OR random* [tw] OR research design [mh:noexp]
OR Meta-Analysis [ptyp] OR systematic review [tw] NOT
(animal [MESH] NOT human [MESH]) NOT case reports
[pt] NOT Comment [PT] NOT letter [PT] NOT childTrials 2009, 10:58 http://www.trialsjournal.com/content/10/1/58
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[MESH] NOT infant [MESH] NOT child [MESH] NOT
infant [MESH])
Abdominal drainage
(Surgery [MESH]) AND (abdominal drain* [tw] OR intra-
peritoneal drain* [tw] OR intraabdominal drain* [tw] OR
prophylactic drain* [tw]) AND (randomized controlled
trial [pt] OR controlled clinical trial [pt] OR randomized
controlled trials [MESH] OR random allocation [MESH]
OR double-blind method [MESH] OR single-blind
method [MESH] OR clinical trial [pt] OR clinical trials
[MESH] OR ("clinical trial" [tw]) OR ((singl* [tw] OR
doubl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind*
[tw])) OR placebos [MESH] OR placebo* [tw] OR ran-
dom* [tw] OR research design [mh:noexp] OR Meta-
Analysis [ptyp] OR systematic review [tw] NOT (animal
[MESH] NOT human [MESH]) NOT case reports [pt] NOT
Comment [PT] NOT letter [PT] NOT child [MESH] NOT
infant [MESH] NOT child [MESH] NOT infant [MESH])
Postoperative feeding
(Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (feeding
[tw] OR postoperative feeding [tw] OR enteral feeding
[tw] OR nasogastric feeding [tw] OR nasojejunal feeding
[tw] OR parenteral nutrition [tw] OR enteral nutrition
[tw]) AND (randomized controlled trial [pt] OR control-
led clinical trial [pt] OR randomized controlled trials
[MESH] OR random allocation [MESH] OR double-blind
method [MESH] OR single-blind method [MESH] OR
clinical trial [pt] OR clinical trials [MESH] OR ("clinical
trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR tripl*
[tw]) AND (mask* [tw] OR blind* [tw])) OR placebos
[MESH] OR placebo* [tw] OR random* [tw] OR research
design [mh:noexp] OR Meta-Analysis [ptyp] OR system-
atic review [tw] NOT (animal [MESH] NOT human
[MESH]) NOT case reports [pt] NOT Comment [PT] NOT
letter [PT] NOT child [MESH] NOT infant [MESH] NOT
child [MESH] NOT infant [MESH])
Patient mobilisation
(Pancreas surgery [tw] OR pancreas resection [tw] OR
pancreatic surgery [tw] OR pancreatic resection [tw] OR
distal pancreatectomy [tw] OR pancreatic left resection
[tw] OR pancreaticoduodenectomy [tw] OR hepatic sur-
gery [tw] OR hepatic resection [tw] OR liver surgery [tw]
OR hepatectomy [tw] OR colorectal surgery [tw] OR colon
resection [tw] OR colon surgery [tw] OR abdominal sur-
gery [tw] OR gastrointestinal surgery [tw]) AND (mobili-
sation [tw] OR mobilization [tw] OR postoperative
mobilisation [tw] OR patient mobilisation [tw] OR post-
operative mobilization [tw] OR patient mobilization
[tw]) AND (randomized controlled trial [pt] OR control-
led clinical trial [pt] OR randomized controlled trials
[MESH] OR random allocation [MESH] OR double-blind
method [MESH] OR single-blind method [MESH] OR
clinical trial [pt] OR clinical trials [MESH] OR ("clinical
trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR tripl*
[tw]) AND (mask* [tw] OR blind* [tw])) OR placebos
[MESH] OR placebo* [tw] OR random* [tw] OR research
design [mh:noexp] OR Meta-Analysis [ptyp] OR system-
atic review [tw] NOT (animal [MESH] NOT human
[MESH]) NOT case reports [pt] NOT Comment [PT] NOT
letter [PT] NOT child [MESH] NOT infant [MESH] NOT
child [MESH] NOT infant [MESH])
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